Biomarker-guided targeted therapy in platinum-resistant ovarian cancer (AMBITION; KGOG 3045): a multicentre, open-label, five-arm, uncontrolled, umbrella trial

by Choi, C.H, Joung, J.-G, Kim, B.-G, Kim, H.S, Kim, J.-W, Kim, S., Korean Gynecologic Oncology Group (KGOG) investigators, Lee, J.B, Lee, J.-Y, Park, E.
Published 2022